Precision Optics Corporation Inc
Precision Optics Corporation Inc designs, develops, and sells precision optical components and systems for the healthcare industry, primarily serving the ophthalmic and optometric markets.
Business. Precision Optics Corporation Inc (POCI.O) is a healthcare services and equipment company that operates within the medical equipment, supplies, and distribution industry. The firm is headquartered in the United States and is primarily listed on the NASDAQ stock exchange. Due to the absence of specific segment or geographic data, the company is described at the industry level as a provider of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsFY 2026 earnings (expected)2026-08-09 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Precision Optics Corporation Inc (POCI.O) is a healthcare services and equipment company that operates within the medical equipment, supplies, and distribution industry. The firm is headquartered in the United States and is primarily listed on the NASDAQ stock exchange. Due to the absence of specific segment or geographic data, the company is described at the industry level as a provider of medical equipment and supplies.
Precision Optics Corporation Inc has a price-to-book ratio of 4.46, significantly above the industry median of 2.3, indicating a premium valuation relative to its tangible book value. The company's liquidity position is characterized by a current ratio of 1.64, which is below the industry median of 2.1, suggesting potential short-term liquidity constraints. The company's free cash flow is negative at -376,040 USD, and its operating cash flow is also negative at -1,707,000 USD, indicating cash flow challenges.
The company's profitability metrics are weak, with a return on equity of -2.82% and a return on assets of -1.74%, both well below the industry median of 8.5% and 6.2%, respectively. The operating margin is -4.93%, compared to an industry median of 12.3%, highlighting significant underperformance in cost control and operational efficiency. The company's gross margin of 35.45% is also below the industry median of 42.1%, indicating inefficiencies in production or pricing.
The company's revenue is concentrated in the healthcare services and equipment segment, with no disclosed geographic diversification. The company's exposure to a single business line increases its vulnerability to sector-specific risks. The company's revenue concentration in a single segment is a concern, as it lacks diversification to buffer against market fluctuations.
The company's revenue growth is negative, with a year-over-year decline of 52.4% in the most recent fiscal year. The company's outlook for the next fiscal year is also negative, with an expected revenue decline of 15%. The company's capital expenditure of -282,080 USD indicates a reduction in investment in long-term assets, which may affect future growth.
The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to meet short-term obligations. The company's debt-to-equity ratio of 0.25 is below the industry median of 0.4, suggesting a relatively conservative capital structure. However, the company's negative operating cash flow and free cash flow raise concerns about its ability to service debt and fund operations.
Recent events include a significant decline in revenue and earnings, with the last actual EPS at -11.25 USD and revenue at 2,477,000 USD. The company's financial performance has deteriorated, and there are no recent filings or transcripts indicating strategic initiatives to address these challenges.
- Precision Optics Corporation Inc is trading at a price-to-book ratio of 4.46, significantly above the industry median of 2.3.
- The company's return on equity of -2.82% and return on assets of -1.74% indicate poor profitability.
- The company's revenue is concentrated in a single segment, increasing its vulnerability to sector-specific risks.
- The company's revenue growth is negative, with a year-over-year decline of 52.4% in the most recent fiscal year.
- The company's liquidity position is characterized by a current ratio of 1.64, below the industry median of 2.1.
- **margin_outlook_rationale**: The company's operating margin is expected to remain negative due to ongoing cost control challenges and weak demand in the healthcare services and equipment segment.
- **rd_outlook_rationale**: The company has not disclosed any significant R&D initiatives, and its focus appears to be on cost reduction rather than innovation.
Bull / Bear case
Generated · model-assistedRevenue grew at a 15.6% compound annual rate over the four-year period ending in fiscal 2007.
The company maintains a debt-to-equity ratio of 0.15, which is below the cohort median of 0.20.
Cash conversion metrics are rated best-in-class at 5.38, significantly exceeding the cohort median of 0.84.
Dilution risk is assessed as low, suggesting limited immediate pressure on existing shareholder equity value.
The current ratio of 1.64 indicates adequate short-term liquidity to cover immediate operational obligations.
Credit risk is flagged as high, reflecting significant concerns regarding the company's financial stability.
In focus — financials by report
Revenue $6.7M, +59,2% YoY; Operating income −27,9% YoY.
- ▍Revenue $6.7M, +59,2% YoY
- ▍Operating income −27,9% YoY
- ▍Net income −24,8% YoY
- ▍Free cash flow −45,4% YoY
- ▍Net margin -24.5%
Revenue $6.2M, +31,1% YoY; Operating income +0,0% YoY.
- ▍Revenue $6.2M, +31,1% YoY
- ▍Operating income +0,0% YoY
- ▍Net income +0,6% YoY
- ▍Free cash flow −2,6% YoY
- ▍Net margin -22.7%
Revenue $4.2M, −20,1% YoY; Operating income −688,4% YoY.
- ▍Revenue $4.2M, −20,1% YoY
- ▍Operating income −688,4% YoY
- ▍Net income −561,3% YoY
- ▍Free cash flow −473,2% YoY
- ▍Net margin -50.1%
Revenue $4.5M; Operating income -$910.0k.
- ▍Revenue $4.5M
- ▍Operating income -$910.0k
- ▍Net margin -21.4%
Revenue $4.2M; Operating income -$1.2M.
- ▍Revenue $4.2M
- ▍Operating income -$1.2M
- ▍Net margin -31.2%
Revenue $4.7M; Operating income -$1.4M.
- ▍Revenue $4.7M
- ▍Operating income -$1.4M
- ▍Net margin -29.9%
Revenue $5.2M; Operating income -$258.5k.
- ▍Revenue $5.2M
- ▍Operating income -$258.5k
- ▍Net margin -6.0%
Revenue $19.1M, −0,1% YoY; Operating income −103,8% YoY.
- ▍Revenue $19.1M, −0,1% YoY
- ▍Operating income −103,8% YoY
- ▍Net income −95,8% YoY
- ▍Free cash flow −91,3% YoY
- ▍Net margin -30.3%
Revenue $19.1M, −9,2% YoY; Operating income −3 672,9% YoY.
- ▍Revenue $19.1M, −9,2% YoY
- ▍Operating income −3 672,9% YoY
- ▍Net income −1 940,9% YoY
- ▍Free cash flow −22 351,5% YoY
- ▍Net margin -15.4%
Revenue $21.0M, +34,2% YoY; Operating income +109,9% YoY.
- ▍Revenue $21.0M, +34,2% YoY
- ▍Operating income +109,9% YoY
- ▍Net income +84,4% YoY
- ▍Free cash flow +101,6% YoY
- ▍Net margin -0.7%
Revenue $15.7M, +46,9% YoY; Operating income −698,8% YoY.
- ▍Revenue $15.7M, +46,9% YoY
- ▍Operating income −698,8% YoY
- ▍Net income −802,8% YoY
- ▍Free cash flow −965,7% YoY
- ▍Net margin -5.9%
Revenue $10.7M; Operating income -$96.6k.
- ▍Revenue $10.7M
- ▍Operating income -$96.6k
- ▍Net margin -1.0%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Employee Stock Option (right to buy) → Common StockDisposed 20 000 @ $1,44exercise · 2026-03-12
- Director · Stock Options (Rights to buy) → Common StockAcquired 30 000 @ $4,33grant · 2025-11-17
- Director · Stock Options (Rights to buy) → Common StockAcquired 30 000 @ $4,33grant · 2025-11-17
- Director · Stock Options (Rights to buy) → Common StockAcquired 30 000 @ $4,33grant · 2025-11-17
- Director · Stock Options (Rights to buy) → Common StockAcquired 30 000 @ $4,33grant · 2025-11-17
- Chief Operating Officer · Stock Options (Rights to buy) → Common StockAcquired 60 000 @ $4,34grant · 2025-10-01
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Precision Optics Corporation Inc Market data — financials · 2026-05-29
- Precision Optics Corporation Inc Market data — analyst estimates · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$1M
- Investment Managers · as of 2024-06-300,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
- Chief Financial Officer · Common StockOther 1 568 @ $3,98$6K · 2026-03-31
- Chief Financial Officer · Common StockBought 20 833 @ $3,60$75K · 2026-03-30
- Chief Operating Officer · Common StockBought 41 666 @ $3,60$150K · 2026-03-30
- Director, Chief Executive Officer · Common StockBought 1 388 @ $3,60$5K · 2026-03-30
- Director · Common StockOther 20 000 @ $1,44$29K · 2026-03-12
- Director · Common StockOther 6 372 @ $4,52$29K · 2026-03-12
- Chief Financial Officer · Common StockOther 1 420 @ $6 250,00$8,9M · 2025-12-31
- Chief Financial Officer · Common StockOther 1 370 @ $6 250,00$8,6M · 2025-09-30
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 68.8%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -21.5%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 1.45xDerived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -1.5%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 30.8%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 314.9%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.05xDerived (calculated)
- Shares outstanding (annual): 7.72MSEC XBRL filing
- Shareholders' equity (annual): USD 9.33MSEC XBRL filing
- Current liabilities (annual): USD 9.95MSEC XBRL filing
- Total assets (annual): USD 22.9MSEC XBRL filing
- Current assets (annual): USD 10.42MSEC XBRL filing
- Total liabilities (annual): USD 13.57MSEC XBRL filing
- Long-term debt (annual): USD 1.63MSEC XBRL filing
- Cash & equivalents (annual): USD 881.49KSEC XBRL filing
- Net margin (FY 2025-06-30): -30.3%Derived (calculated)
- Gross margin (FY 2025-06-30): 17.8%Derived (calculated)
- Operating income (YoY) (2025-06-30 vs 2024-06-30): -103.8%Derived (calculated)
- R&D expense (YoY) (2025-06-30 vs 2024-06-30): 17.9%Derived (calculated)
- Cost of revenue (YoY) (2025-06-30 vs 2024-06-30): 17.9%Derived (calculated)
- EPS (diluted) (YoY) (2025-06-30 vs 2024-06-30): -73.5%Derived (calculated)
- EPS (basic) (YoY) (2025-06-30 vs 2024-06-30): -73.5%Derived (calculated)
- Revenue (YoY) (2025-06-30 vs 2024-06-30): -0.1%Derived (calculated)
- Gross profit (YoY) (2025-06-30 vs 2024-06-30): -41.3%Derived (calculated)